Legal & General Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.28M Buy
157,703
+5,238
+3% +$42.4K ﹤0.01% 2166
2025
Q1
$1.28M Buy
152,465
+1,756
+1% +$14.7K ﹤0.01% 2090
2024
Q4
$1.19M Buy
150,709
+20,068
+15% +$159K ﹤0.01% 2173
2024
Q3
$1.09M Buy
130,641
+393
+0.3% +$3.27K ﹤0.01% 2205
2024
Q2
$827K Buy
130,248
+14,823
+13% +$94.1K ﹤0.01% 2258
2024
Q1
$699K Buy
115,425
+28,999
+34% +$176K ﹤0.01% 2311
2023
Q4
$525K Buy
86,426
+76,124
+739% +$462K ﹤0.01% 2431
2023
Q3
$43.5K Sell
10,302
-1,287
-11% -$5.43K ﹤0.01% 2883
2023
Q2
$36K Sell
11,589
-9,404
-45% -$29.2K ﹤0.01% 2917
2023
Q1
$29.2K Sell
20,993
-22,522
-52% -$31.3K ﹤0.01% 2970
2022
Q4
$86.6K Buy
43,515
+3,557
+9% +$7.08K ﹤0.01% 2847
2022
Q3
$81K Buy
39,958
+1,528
+4% +$3.1K ﹤0.01% 2874
2022
Q2
$122K Sell
38,430
-591
-2% -$1.88K ﹤0.01% 2795
2022
Q1
$163K Sell
39,021
-62,612
-62% -$262K ﹤0.01% 2734
2021
Q4
$487K Hold
101,633
﹤0.01% 2424
2021
Q3
$543K Buy
101,633
+18,694
+23% +$99.9K ﹤0.01% 2392
2021
Q2
$425K Hold
82,939
﹤0.01% 2366
2021
Q1
$559K Buy
82,939
+365
+0.4% +$2.46K ﹤0.01% 2286
2020
Q4
$377K Sell
82,574
-216
-0.3% -$986 ﹤0.01% 2309
2020
Q3
$322K Sell
82,790
-4,349
-5% -$16.9K ﹤0.01% 2281
2020
Q2
$415K Sell
87,139
-2,181
-2% -$10.4K ﹤0.01% 2213
2020
Q1
$310K Buy
89,320
+38,426
+76% +$133K ﹤0.01% 2189
2019
Q4
$245K Buy
50,894
+8,739
+21% +$42.1K ﹤0.01% 2350
2019
Q3
$122K Buy
42,155
+4,448
+12% +$12.9K ﹤0.01% 2466
2019
Q2
$270K Buy
37,707
+2,816
+8% +$20.2K ﹤0.01% 2269
2019
Q1
$495K Buy
34,891
+386
+1% +$5.48K ﹤0.01% 2153
2018
Q4
$467K Buy
34,505
+1,810
+6% +$24.5K ﹤0.01% 2132
2018
Q3
$726K Buy
32,695
+5,596
+21% +$124K ﹤0.01% 2037
2018
Q2
$445K Buy
+27,099
New +$445K ﹤0.01% 2141